Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PIII
Upturn stock ratingUpturn stock rating

P3 Health Partners Inc (PIII)

Upturn stock ratingUpturn stock rating
$8.89
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/22/2025: PIII (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit 155.42%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/22/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.75B USD
Price to earnings Ratio -
1Y Target Price 16.25
Price to earnings Ratio -
1Y Target Price 16.25
Volume (30-day avg) 18212
Beta 0.95
52 Weeks Range 7.00 - 40.50
Updated Date 04/25/2025
52 Weeks Range 7.00 - 40.50
Updated Date 04/25/2025
Dividends yield (FY) -
Basic EPS (TTM) -54

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -9.05%
Operating Margin (TTM) -35.19%

Management Effectiveness

Return on Assets (TTM) -24.23%
Return on Equity (TTM) -106.44%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 158347305
Price to Sales(TTM) 2.5
Enterprise Value 158347305
Price to Sales(TTM) 2.5
Enterprise Value to Revenue 0.11
Enterprise Value to EBITDA -1.86
Shares Outstanding 3263190
Shares Floating 1141791
Shares Outstanding 3263190
Shares Floating 1141791
Percent Insiders 61.91
Percent Institutions 13.53

Analyst Ratings

Rating 4
Target Price 31.25
Buy -
Strong Buy 2
Buy -
Strong Buy 2
Hold 2
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

P3 Health Partners Inc

stock logo

Company Overview

overview logo History and Background

P3 Health Partners Inc. was founded in 2016. It focuses on population health management and value-based care for seniors.

business area logo Core Business Areas

  • Value-Based Care: Provides coordinated care through a network of primary care physicians and specialists, focusing on preventive care and chronic disease management.
  • Risk-Bearing Partnerships: Partners with health plans and provider groups to manage the health of their members under risk-based contracts.
  • Data Analytics and Technology: Utilizes data analytics and technology platforms to identify high-risk patients, improve care coordination, and optimize healthcare delivery.

leadership logo Leadership and Structure

Dr. Sherif Abdou is the current CEO. The organizational structure includes teams focused on clinical operations, network management, data analytics, and finance.

Top Products and Market Share

overview logo Key Offerings

  • P3 Care Model: A comprehensive care delivery model that integrates primary care, specialty care, and care management services. Market share is difficult to ascertain precisely, but P3 operates in a competitive landscape with rivals such as Oak Street Health (OSH) and Agilon Health (AGL). Focuses on Medicare Advantage patients.
  • Network of Providers: A network of affiliated primary care physicians and specialists who deliver care to P3's patients. Revenue tied to contracts with health plans and provider groups.
  • Data Analytics Platform: Their proprietary software to manage patient data. Competitors in the Healthcare analytics field include Cerner (now Oracle) and Allscripts.

Market Dynamics

industry overview logo Industry Overview

The healthcare industry is shifting towards value-based care models, driven by rising healthcare costs and a focus on improving patient outcomes. The Medicare Advantage market is growing rapidly.

Positioning

P3 Health Partners is positioned as a leader in the value-based care space, particularly for seniors. The company differentiates itself through its integrated care model and focus on data analytics.

Total Addressable Market (TAM)

The TAM for value-based care is estimated to be in the hundreds of billions of dollars, driven by the growing Medicare Advantage market. P3 is positioned to capture a significant share of this market through its expansion into new geographies and partnerships.

Upturn SWOT Analysis

Strengths

  • Integrated care model
  • Strong network of providers
  • Data analytics capabilities
  • Focus on value-based care

Weaknesses

  • Relatively small size compared to competitors
  • Geographic concentration in certain markets
  • Dependence on key partnerships

Opportunities

  • Expansion into new geographic markets
  • Partnerships with additional health plans and provider groups
  • Growth of the Medicare Advantage market
  • Acquisition of smaller value-based care providers

Threats

  • Increased competition from larger players
  • Changes in healthcare regulations
  • Economic downturn
  • Inability to retain providers in their network

Competitors and Market Share

competitor logo Key Competitors

  • OSH
  • AGL
  • CHE
  • HUM

Competitive Landscape

P3 Health Partners faces intense competition from larger, more established players. It attempts to distinguish itself with its integrated approach.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Past growth has been marked by geographic expansion and increased partnerships. Review past annual reports for growth statistics.

Future Projections: Analyst projections depend on the company's strategic initiatives and financial performance. Check financial news outlets for updated analyst estimates.

Recent Initiatives: Focus on technology integration, network expansion, and cost management are key initiatives. News releases will be helpful.

Summary

P3 Health Partners operates in a competitive value-based care market. While their integrated approach and data analytics offer advantages, smaller size and geographic concentration present challenges. Future success depends on strategic expansion and strong partnerships, but with low market share, and an aggressive growth market, it's a high risk, high reward stock. Overall, P3 Health Partners operates in a competitive market and faces challenges related to its size and geographic concentration, making it a speculative investment.

Similar Companies

AGLratingrating

agilon health Inc

$3.57
Small-Cap Stock
29.82%
Consider higher Upturn Star rating
BUY since 21 days

AGLratingrating

agilon health Inc

$3.57
Small-Cap Stock
BUY since 21 days
29.82%
Consider higher Upturn Star rating

CHEratingrating

Chemed Corp

$579.5
Mid-Cap Stock
0.62%
SELL
SELL since 2 days

CHEratingrating

Chemed Corp

$579.5
Mid-Cap Stock
SELL since 2 days
0.62%
SELL

HUMratingrating

Humana Inc

$258.92
Large-Cap Stock
-12.24%
WEAK BUY
BUY since 7 days

HUMratingrating

Humana Inc

$258.92
Large-Cap Stock
BUY since 7 days
-12.24%
WEAK BUY

UNHratingrating

UnitedHealth Group Incorporated

$427.18
Large-Cap Stock
-18.34%
WEAK BUY
BUY since 15 days

UNHratingrating

UnitedHealth Group Incorporated

$427.18
Large-Cap Stock
BUY since 15 days
-18.34%
WEAK BUY

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Market Research Reports
  • Financial News Outlets

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary based on source. Always consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About P3 Health Partners Inc

Exchange NASDAQ
Headquaters Henderson, NV, United States
IPO Launch date 2021-04-06
CEO & President Dr. Aric Coffman M.D.
Sector Healthcare
Industry Medical Care Facilities
Full time employees 360
Full time employees 360

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​